Immuno-Oncology 360° Summit

07/02/2018 - 09/02/2018
The Roosevelt Hotel, NYC, USA

Immuno-Oncology 360° is a comprehensive program providing exposure to the entire spectrum of R&D, addressing key aspects from all facets of IO including:

  • Discovery / Preclinical Science

  • Translational Science

  • Clinical Development

  • Business Aspects

  • Investor Relations

  • Emerging Technologies

  • Biomarkers / Diagnostics

  • Trends in the Field

Dr Axel HoosGSK and Dr James GulleyNCI, together led the design of the 4th annual Immuno-Oncology 360° program to include 45 speakers and over 30 talks. We are delighted to announce that Dr Andrew Baum is confirmed as the investor relations plenary keynote.